evidencegaps
Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

1,495 questions · 1,554 findings · 140 reviews · Heart

Sort:Best matchNewestHighest certaintyDownload CSV
No studies found 272 · 17.5%GRADE not reported 44 · 2.8%Very low 329 · 21.2%Low 464 · 29.9%Moderate 319 · 20.5%High 126 · 8.1%

Lidocaine vs disopyramide

Ventricular fibrillation · patients with myocardial infarction

It is very uncertain whether lidocaine changes ventricular fibrillation compared with disopyramide (very low certainty).

1 finding from 1 review

Lidocaine vs disopyramide

Adverse events (AEs; adverse drug reaction): asystole · patients with myocardial infarction

It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): asystole compared with disopyramide (very low certainty).

1 finding from 1 review

Lidocaine vs disopyramide

Adverse events (AEs; adverse drug reaction): sinoatrial block · patients with myocardial infarction

It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): sinoatrial block compared with disopyramide (very low certainty).

1 finding from 1 review

Lidocaine vs disopyramide

Adverse events (AEs; adverse drug reaction): cardiac blocks (high‐degree atrioventricular block and bundle) · patients with myocardial infarction

It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): cardiac blocks… compared with disopyramide (very low certainty).

1 finding from 1 review

Lidocaine vs tocainide

All‐cause mortality · patients with myocardial infarction

It is very uncertain whether lidocaine changes all‐cause mortality compared with tocainide (very low certainty).

1 finding from 1 review

Lidocaine vs tocainide

Cardiac mortality · patients with myocardial infarction

It is very uncertain whether lidocaine changes cardiac mortality compared with tocainide (very low certainty).

1 finding from 1 review

Lidocaine vs tocainide

Adverse events (AEs) (1 or more events) · patients with myocardial infarction

It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): any adverse event compared with tocainide (very low certainty).

1 finding from 1 review

Lidocaine vs mexiletine

All‐cause mortality · patients with myocardial infarction

It is very uncertain whether lidocaine changes all‐cause mortality compared with mexiletine (very low certainty).

1 finding from 1 review

Lidocaine vs mexiletine

Cardiac mortality · patients with myocardial infarction

It is very uncertain whether lidocaine changes cardiac mortality compared with mexiletine (very low certainty).

1 finding from 1 review

Lidocaine vs mexiletine

Ventricular fibrillation · patients with myocardial infarction

It is very uncertain whether lidocaine changes ventricular fibrillation compared with mexiletine (very low certainty).

1 finding from 1 review

Lidocaine vs mexiletine

Adverse events (AEs; adverse drug reaction): atrioventricular block · patients with myocardial infarction

It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): atrioventricular block compared with mexiletine (very low certainty).

1 finding from 1 review

Lidocaine vs mexiletine

Adverse events (AEs; adverse drug reaction): composite neurological adverse event (confusion, vertigo, nystagmus, vomiting and diplopia) · patients with myocardial infarction

It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): composite neurological… compared with mexiletine (very low certainty).

1 finding from 1 review